Τίτλος:
Management of depressive symptoms in peri- and postmenopausal women: EMAS position statement
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Introduction: Globally, the total number of people with depression exceeds 300 million, and the incidence rate is 70 % greater in women. The perimenopause is considered to be a time of increased risk for the development of depressive symptoms and major depressive episodes. Aim: The aim of this position statement is to provide a comprehensive model of care for the management of depressive symptoms in perimenopausal and early menopausal women, including diagnosis, treatment and follow-up. The model integrates the care provided by all those involved in the management of mild or moderate depression in midlife women. Materials and methods: Literature review and consensus of expert opinion. Summary recommendations: Awareness of depressive symptoms, early detection, standardized diagnostic procedures, personalized treatment and a suitable follow-up schedule need to be integrated into healthcare systems worldwide. Recommended treatment comprises antidepressants, psychosocial therapies and lifestyle changes. Alternative and complementary therapies, although widely used, may help with depression, but a stronger evidence base is needed. Although not approved for this indication, menopausal hormone therapy may improve depressive symptoms in peri- but not in postmenopausal women, especially in those with vasomotor symptoms. © 2019
Συγγραφείς:
Stute, P.
Spyropoulou, A.
Karageorgiou, V.
Cano, A.
Bitzer, J.
Ceausu, I.
Chedraui, P.
Durmusoglu, F.
Erkkola, R.
Goulis, D.G.
Lindén Hirschberg, A.
Kiesel, L.
Lopes, P.
Pines, A.
Rees, M.
van Trotsenburg, M.
Zervas, I.
Lambrinoudaki, I.
Εκδότης:
Elsevier Ireland Ltd
Λέξεις-κλειδιά:
antidepressant agent; estradiol; isoflavone derivative; melatonin; tibolone; hormone, alternative medicine; Article; climacterium; depression; dietary supplement; female; hormonal therapy; human; Hypericum perforatum; lifestyle modification; postmenopause; psychosocial care; psychotherapy; randomized controlled trial (topic); systematic review (topic); adult; aged; climacterium; depression; Europe; lifestyle; major depression; medical society; menopause; middle aged; postmenopause; practice guideline; psychology; treatment outcome, Adult; Aged; Antidepressive Agents; Complementary Therapies; Depression; Depressive Disorder, Major; Europe; Female; Hormones; Humans; Life Style; Menopause; Middle Aged; Perimenopause; Postmenopause; Practice Guidelines as Topic; Societies, Medical; Treatment Outcome
DOI:
10.1016/j.maturitas.2019.11.002
